PGBD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.15339959805283E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.08100000009814E-07 |
Normal-vs-Stage2 |
7.73210000000191E-05 |
Normal-vs-Stage3 |
8.90076901072234E-12 |
Normal-vs-Stage4 |
5.50349998906796E-09 |
Stage1-vs-Stage2 |
8.435600E-01 |
Stage1-vs-Stage3 |
4.342700E-03 |
Stage1-vs-Stage4 |
3.035600E-02 |
Stage2-vs-Stage3 |
6.899800E-02 |
Stage2-vs-Stage4 |
1.587200E-01 |
Stage3-vs-Stage4 |
8.116400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.49817960657128E-12 |
Normal-vs-AfricanAmerican |
9.916500E-03 |
Normal-vs-Asian |
3.257200E-01 |
Caucasian-vs-AfricanAmerican |
9.564400E-02 |
Caucasian-vs-Asian |
1.496620E-01 |
AfricanAmerican-vs-Asian |
7.050600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.58078061330525E-12 |
Normal-vs-Female |
1.05750000001237E-06 |
Male-vs-Female |
2.096100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.81569999999376E-06 |
Normal-vs-Age(41-60Yrs) |
9.26059999795115E-08 |
Normal-vs-Age(61-80Yrs) |
7.17490511448204E-11 |
Normal-vs-Age(81-100Yrs) |
1.176960E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.614600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.594000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.923600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.257400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.332200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.926000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.443600E-01 |
Normal-vs-Grade 2 |
2.9790000022345E-08 |
Normal-vs-Grade 3 |
8.92789953077511E-10 |
Normal-vs-Grade 4 |
1.30639943307642E-11 |
Grade 1-vs-Grade 2 |
3.454200E-01 |
Grade 1-vs-Grade 3 |
2.284600E-01 |
Grade 1-vs-Grade 4 |
9.116500E-02 |
Grade 2-vs-Grade 3 |
1.700220E-01 |
Grade 2-vs-Grade 4 |
1.981600E-03 |
Grade 3-vs-Grade 4 |
4.906200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.58670000027783E-07 |
Normal-vs-ccB subtype |
5.25000043438695E-11 |
ccA subtype-vs-ccB subtype |
7.963500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.27659998922547E-09 |
Normal-vs-N1 |
3.415600E-03 |
N0-vs-N1 |
8.450400E-01 |
|
|